(www.cnbc.com)

249 points randycupertino | 1 comments | 16 Nov 25 23:01 UTC | HN request time: 0.199s | source

It is for startups that can absorb billions then close their doors.

It’s not sustainable for businesses who rely on sickness.

Goldman Sachs asks in biotech Report: Is curing patients a sustainable business? (2018)